Villa-Crespo, L.; Podlipnik, S.; Anglada, N.; Izquierdo, C.; Giavedoni, P.; Iglesias, P.; Dominguez, M.; Aya, F.; Arance, A.; Malvehy, J.;
et al. Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival. Cancers 2022, 14, 1237.
https://doi.org/10.3390/cancers14051237
AMA Style
Villa-Crespo L, Podlipnik S, Anglada N, Izquierdo C, Giavedoni P, Iglesias P, Dominguez M, Aya F, Arance A, Malvehy J,
et al. Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival. Cancers. 2022; 14(5):1237.
https://doi.org/10.3390/cancers14051237
Chicago/Turabian Style
Villa-Crespo, Lorena, Sebastian Podlipnik, Natalia Anglada, Clara Izquierdo, Priscila Giavedoni, Pablo Iglesias, Mireia Dominguez, Francisco Aya, Ana Arance, Josep Malvehy,
and et al. 2022. "Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival" Cancers 14, no. 5: 1237.
https://doi.org/10.3390/cancers14051237
APA Style
Villa-Crespo, L., Podlipnik, S., Anglada, N., Izquierdo, C., Giavedoni, P., Iglesias, P., Dominguez, M., Aya, F., Arance, A., Malvehy, J., Puig, S., & Carrera, C.
(2022). Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival. Cancers, 14(5), 1237.
https://doi.org/10.3390/cancers14051237